Work

A phase 2 study of a nivolumab (nivo)-containing regimen in patients (pts) with newly diagnosed classical Hodgkin lymphoma (cHL): Study 205 Cohort D.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps7573

Authors: Philippe Armand, Margaret Ann Shipp, John Kuruvilla, Graham P Collins, Rod Ramchandren, John Timmerman, Anne Sumbul, Mary M. Ruisi, Kazunobu Kato, Stephen Maxted Ansell

Institutions: Dana-Farber Cancer Institute, Princess Margaret Cancer Centre, Churchill Hospital, The Barbara Ann Karmanos Cancer Institute, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Bristol-Myers Squibb (United States), Mayo Clinic

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2502404786

Cites:

Cited by: 4

Related to: 10